Literature DB >> 32420810

Circular RNA ABCB10 promotes non-small cell lung cancer progression by increasing E2F5 expression through sponging miR-584-5p.

Dongjie Ma1,2, Yingzhi Qin1,2, Cheng Huang1,2, Yeye Chen1,2, Zhijun Han1,2, Xiaoyun Zhou1,2, Hongsheng Liu1,2.   

Abstract

BACKGROUND/AIMS: CircABCB10 function as an endogenous miRNA sponge plays an important role in various tumors. This experimental design was based on circABCB10 to explore the pathogenesis of non-small cell lung cancer (NSCLC).
Methods: CircRNA microarray was used to examine circRNA expression profiles in lung cancer from 3 NSCLC patients and paired healthy lung tissues. The expression of circABCB10 and miR-584-5p was detected by q-PCR. CCK-8, colony formation, and transwell assays to study the circABCB10 effects on tumor cell growth and cell migration invasiveness. To validate downstream target genes of circABCB10 and miR-584-5p detected by luciferase reporter assays. RT-qPCR and Western blotting were used to study E2F5 expression. The tumor growth was detected by nude mice in vivo.
Results: We analyzed the human circRNA expression profile in NSCLC tissues. CircABCB10 was identified as a circRNA that increased in NSCLC tissues. CircABCB10 was noticeably raised in NSCLC, and high circABCB10 expression was related to low survival in NSCLC patients. Silencing of circABCB10 suppressed non-small cell lung cancer cell migration, cell proliferation, and invasion.CircABCB10 can act as a sponge of miR-584-5p to up-regulate E2F5 expression level. E2F5 knockdown or overexpress of miR-584-5p gene reversed the circABCB10 who has carcinogenic effects. There was a negative correlation expression between the circABCB10 and miR-584-5p gene, and There was a positive relationship between the expression of circABCB10 and E2F5 in NSCLC tumors.
Conclusion: CircABCB10 promoted the progression of NSCLC by modulating the miR-584-5p/E2F5 axis. ABBREVIATION: NSCLC: non-small cell lung cancer; circ RNA: circular RNA; miRNA: micro RNA.

Entities:  

Keywords:  Mir-584-5p; NSCLC; circABCB10; invasion; proliferation

Mesh:

Substances:

Year:  2020        PMID: 32420810      PMCID: PMC7469616          DOI: 10.1080/15384101.2020.1761617

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  38 in total

1.  Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.

Authors:  Jung-Jyh Hung; Wen-Juei Jeng; Wen-Hu Hsu; Teh-Ying Chou; Biing-Shiun Huang; Yu-Chung Wu
Journal:  J Thorac Oncol       Date:  2012-07       Impact factor: 15.609

2.  Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis.

Authors:  Yan Li; Qiupeng Zheng; Chunyang Bao; Shuyi Li; Weijie Guo; Jiang Zhao; Di Chen; Jianren Gu; Xianghuo He; Shenglin Huang
Journal:  Cell Res       Date:  2015-07-03       Impact factor: 25.617

Review 3.  Circular RNAs in cancer: novel insights into origins, properties, functions and implications.

Authors:  Jingqiu Li; Jie Yang; Ping Zhou; Yanping Le; Chengwei Zhou; Shaomin Wang; Dazhi Xu; Hui-Kuan Lin; Zhaohui Gong
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

4.  Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors.

Authors:  J Polanowska; L Le Cam; B Orsetti; H Vallés; E Fabbrizio; L Fajas; S Taviaux; C Theillet; C Sardet
Journal:  Genes Chromosomes Cancer       Date:  2000-05       Impact factor: 5.006

5.  Using circular RNA as a novel type of biomarker in the screening of gastric cancer.

Authors:  Peifei Li; Shengcan Chen; Huilin Chen; Xiaoyan Mo; Tianwen Li; Yongfu Shao; Bingxiu Xiao; Junming Guo
Journal:  Clin Chim Acta       Date:  2015-02-14       Impact factor: 3.786

6.  MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.

Authors:  GuiFeng Lu; YaLing Sun; ShengLi An; SaiNan Xin; XiaoLi Ren; Dan Zhang; PingXiang Wu; WenTing Liao; YanQing Ding; Li Liang
Journal:  Exp Mol Pathol       Date:  2015-06-20       Impact factor: 3.362

7.  Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.

Authors:  Alice T Shaw; Beow Y Yeap; Mari Mino-Kenudson; Subba R Digumarthy; Daniel B Costa; Rebecca S Heist; Benjamin Solomon; Hannah Stubbs; Sonal Admane; Ultan McDermott; Jeffrey Settleman; Susumu Kobayashi; Eugene J Mark; Scott J Rodig; Lucian R Chirieac; Eunice L Kwak; Thomas J Lynch; A John Iafrate
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

8.  Identification and functional characterization of circRNA-0008717 as an oncogene in osteosarcoma through sponging miR-203.

Authors:  Xiang Zhou; Dimple Natino; Zili Qin; Dong Wang; Zhen Tian; Xuan Cai; Bo Wang; Xijing He
Journal:  Oncotarget       Date:  2017-12-20

Review 9.  An emerging function of circRNA-miRNAs-mRNA axis in human diseases.

Authors:  Dawei Rong; Handong Sun; Zhouxiao Li; Shuheng Liu; Chaoxi Dong; Kai Fu; Weiwei Tang; Hongyong Cao
Journal:  Oncotarget       Date:  2017-07-10

10.  Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.

Authors:  Qing Li; Zheng Li; Song Wei; Weizhi Wang; Zheng Chen; Lei Zhang; Liang Chen; Bowen Li; Guangli Sun; Jianghao Xu; Qiang Li; Lu Wang; Zhipeng Xu; Yiwen Xia; Diancai Zhang; Hao Xu; Zekuan Xu
Journal:  J Exp Clin Cancer Res       Date:  2017-04-21
View more
  10 in total

1.  Circular RNA circ-ABCB10 Promotes Proliferation and Inhibits Apoptosis of Laryngeal Carcinoma by Inhibiting KLF6.

Authors:  Zhuxiang Chen; Zhimin Zhang; Zhang Zhao
Journal:  Comput Math Methods Med       Date:  2022-06-15       Impact factor: 2.809

2.  Circular RNA circ_0010235 sponges miR-338-3p to play oncogenic role in proliferation, migration and invasion of non-small-cell lung cancer cells through modulating KIF2A.

Authors:  Yanan Zhu; Chunling Ma; Aiai Lv; Changwei Kou
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

3.  [Research Progress in CircRNA and Radiotherapy Resistance of Non-small Cell Lung Cancer].

Authors:  Weilong Li; Shenglin Ma; Shirong Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-11-20

4.  The circ-PITX1 promotes non-small cell lung cancer development via the miR-30e-5p/ITGA6 axis.

Authors:  Wei Li; Pan Yang; Chucheng Zhong; Xiaozhen Shen; Xingyuan Shi; Xiaoping Li
Journal:  Cell Cycle       Date:  2022-01-10       Impact factor: 4.534

Review 5.  CircRNAs: a family number of miRNA regulatory transcriptome in laryngeal carcinoma.

Authors:  Limin Miao; Guanying Feng; Hua Yuan
Journal:  J Clin Lab Anal       Date:  2021-10-07       Impact factor: 2.352

Review 6.  Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer.

Authors:  Ying Liu; Xiang Ao; Wanpeng Yu; Yuan Zhang; Jianxun Wang
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-19       Impact factor: 8.886

7.  Identification of potential circular RNA biomarkers in lung adenocarcinoma: A bioinformatics analysis and retrospective clinical study.

Authors:  Yonggang Zhu; Feng Cao; Fei Liu; Sihua Liu; Lingjiao Meng; Lina Gu; Hanjun Zhao; Meixiang Sang; Baoen Shan
Journal:  Oncol Lett       Date:  2022-03-11       Impact factor: 2.967

8.  hsa_circ_0084811 Regulates Cell Proliferation and Apoptosis in Retinoblastoma through miR-18a-5p/miR-18b-5p/E2F5 Axis.

Authors:  Guangwei Jiang; Mingxuan Qu; Lili Kong; Xiaoming Song; Shanhao Jiang
Journal:  Biomed Res Int       Date:  2022-07-19       Impact factor: 3.246

Review 9.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

10.  circRNA 001306 enhances hepatocellular carcinoma growth by up-regulating CDK16 expression via sponging miR-584-5p.

Authors:  Qian Liu; Cixiao Wang; Zeyou Jiang; Shan Li; Fang Li; Hua-Bing Tan; Su-Yang Yue
Journal:  J Cell Mol Med       Date:  2020-11-01       Impact factor: 5.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.